Pentoxifylline inhibits lipopolysaccharide-induced serum tumor necrosis factor and mortality
- 31 December 1989
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 47 (12), 1023-1029
- https://doi.org/10.1016/0024-3205(90)90474-6
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- ARDS, Neutrophils, and PentoxifyllineAmerican Review of Respiratory Disease, 1988
- Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxofyllineBiochemical and Biophysical Research Communications, 1988
- Detection of Circulating Tumor Necrosis Factor after Endotoxin AdministrationNew England Journal of Medicine, 1988
- Tumor Necrosis Factor in HumansNew England Journal of Medicine, 1988
- Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemiaNature, 1987
- Tumor Necrosis Factor: A Cytokine Involved in Toxic Effects of EndotoxinClinical Infectious Diseases, 1987
- Cachectin: More Than a Tumor Necrosis FactorNew England Journal of Medicine, 1987
- Shock and Tissue Injury Induced by Recombinant Human CachectinScience, 1986
- Pentoxifylline in the Treatment of Experimental Peritonitis in RatsArchives of Surgery, 1985
- Permanent cannulation of aorta and vena cava in rats and ground squirrelsJournal of Applied Physiology, 1960